Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial

Global risk mapping for major diseases transmitted by Aedes aegypti and Aedes albopictus

Samson Leta, Tariku J. Beyene, Eva M. De Clercq et al. · International Journal of Infectious Diseases · 2017 · 553 citations · Full text

Veterinary Medicine, Infectious Diseases, Epidemiology +16

Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005–2006 outbreak on Réunion

A Economopoulou, M. Dominguez, B Helynck et al. · Epidemiology and Infection · 2008 · 549 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +16

High Level of Vector Competence of Aedes aegypti and Aedes albopictus from Ten American Countries as a Crucial Factor in the Spread of Chikungunya Virus

Anubis Vega-Rúa, Karima Zouache, Romain Girod et al. · Journal of Virology · 2014 · 486 citations · Full text

Veterinary Medicine, Entomology, Infectious Diseases +17

Genome-Scale Phylogenetic Analyses of Chikungunya Virus Reveal Independent Emergences of Recent Epidemics and Various Evolutionary Rates

Sara M. Volk, Rubing Chen, Konstantin A. Tsetsarkin et al. · Journal of Virology · 2010 · 424 citations · Full text

Life Sciences, Evolutionary Biology, Genetics +17

Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218.

Robert Edelman, Carol O. Tacket, Steven S. Wasserman et al. · American Journal of Tropical Medicine and Hygiene · 2000 · 365 citations

Veterinary Medicine, Immunology, Infectious Diseases +17